Oxiracetam Nootropic Brain améliorant l'ingrédient chimique intelligent
Nom du produit: Oxiracetam
Synonymes: 4-HYDROXY-2-OXOPYRROLIDINE-N-ACÉTAMIDE;4-hydroxy-2-oxo-1-pyrrolidineacétamide;4-hydroxy-2-oxo-1-pyrrolidineacétamide;4-hydroxypiracétam;OXIRACETAM
CAS: 62613-82-5
MF: C6H10N2O3
MW: 158.16
Chemical Properties Whie Solid
Point de fusion: 165-168 °C
Density : 1.416
Oxiracetam 99% Chemical
Utilisations d'oxiracetam: Nootropique. Analogue de Piracetam avec activité psychostimulante.
Indications et utilisation Oxiracétam, Piracétam et Aniracétam, sont trois médicaments couramment utilisés pour améliorer le métabolisme cérébral et sont des dérivés de la pyrrolidone. Ils ont été développés en 1974 by the Italian company ICF and went on sale in 1987.
Oxiracetam is a Piracetam derivative and excites the central nervous system, promotes brain metabolism, significantly increases and promotes memory retention, and effectively treats senile memory and mental decline. It is used to treat brain dysfunction psychiatric syndrome and mental disorders. It can improve the memory and learning abilities of patients with senile dementia or memory disorders. It is suitable for treating neural dysfunction, memory disorder and intelligence disorders caused by brain damage. It can also be used as a recovery treatment for neurosis, brain trauma, encephalitis, and other brain diseases. Oxiracetam’s greatest advantage is that it is very soluble in water, making it suitable for injection. Research shows that Oxiracetam has higher pharmacological activity and significant curative effects compared to Piracetam.
Oxiracetam Mechanisms of Action Oxiracetam’s mechanisms of action are similar to those of Piracetam. It promotes the binding of phosphorylcholine and phosphoethanolamine, increases the ratio of ATP/ADP in the brain, and increases the binding of protein with nucleic acids in the brain, thus improving the memory and learning ability of patients with senile dementia and memory disorder.
Pharmacokinetics After intake, most of the drug will not accumulate in the body and will be excreted through urine in its original form. It is well-absorbed and well-tolerated.
Clinical Research Animal trials showed that in all types of behavioral experiments, Oxiracetam can improve memory retention and learning ability, reduce brain shocks’ damage on memory, and prevent the learning abilities of rats suffering from spontaneous hypertensive cerebrovascular injury from decreasing. It can also increase acetylcholine circulation in rats’ skin and hippocampus, thus increasing affinity for choline uptake.
Oxiracetam Pharma Materials Chemical Tests (COA) :
Product name
|
Oxiracetam
|
CAS
n ° CAS.
|
62613-82-5
|
Outer Packing
|
25KG
25KG/drum
|
Date de production
|
2017.03.20
|
Durée de conservation
|
2019.03.19
|
Norme adoptée
|
Norme d'entreprise.
|
Éléments d'analyse
|
spécification
|
Résultats
|
Apparence
|
Poudre cristalline blanche
|
Conforme
|
Identification
|
Conforme
|
Conforme
|
Point de fusion
|
167ºC~170ºC
167ºC~170ºC
|
168.7ºC~169.6ºC
168.7ºC~169.6ºC
|
(470nm 1%)
Transmittance of 1% aqueous solution at 470nm
|
≥ 99%
NLT 99%
|
99.6%
99.6%
|
Ammonium ion
|
≤10 ppm
NMT 10 ppm
|
Conforme
|
Chlorides
|
≤50 ppm
NMT 50 ppm
|
Conforme
|
Residue on ignition
|
≤0.1%
NMT 0.1%
|
0.04%
0.04%
|
Heavy metals
|
≤10 ppm
NMT 10 ppm
|
Conforme
|
Perte au séchage
|
≤1.0%
NMT 1.0%
|
0.37%
0.37%
|
Residual solvent
|
≤ 600 ppm
NMT 600 ppm
|
Conforme
|
Single impurity
|
≤0.1%
NMT 0.1%
|
0.04%
0.04%
|
Total impurities
|
≤0.1%
NMT 0.1 %
|
0.06%
0.06%
|
Essai
|
≥99.0%
NMT 99.0%
|
99.8 %
99.8 %
|
Conclusion
|
Qualifié
|